AT7577-E1.0-Preliminary

合集下载

tek071

tek071

tek071Title: tek071Introduction:The technological world is rapidly advancing, with new innovations and discoveries shaping various industries. In this document, we will explore the fascinating world of tek071, its applications, benefits, and potential impact on different sectors. With a focus on the advancements in technologies, we will delve into the key aspects, challenges, and future prospects tied to tek071.1. Understanding tek071:Tek071 refers to a revolutionary technology that has garnered significant attention in recent years. It represents a combination of cutting-edge tools, techniques, and methodologies aimed at enhancing efficiency, productivity, and performance across diverse domains. With its ability to streamline processes, tek071 promises to revolutionize different sectors, including manufacturing, healthcare, transportation, and communication.2. Applications of tek071:2.1 Manufacturing Industry:In the manufacturing sector, tek071 can bring about significant improvements in automation, quality control, and supply chain management. Automated assembly lines, robotic arms, and advanced machine learning algorithms powered by tek071 can enhance productivity, reduce errors, and optimize resource allocation. This can lead to increased production outputs, improved product quality, and reduced costs.2.2 Healthcare Industry:Tek071 has the potential to reshape the healthcare industry, revolutionizing patient care, diagnostics, and medical research. Technological advancements in telemedicine, wearable devices, and artificial intelligence (AI) can improve diagnosis accuracy, facilitate remote consultations, and enable real-time patient monitoring. Furthermore, tek071 can aid in identifying patterns and trends in large datasets, enabling personalized treatments, disease prevention, and early detection.2.3 Transportation Sector:Tek071 is also set to transform the transportation industry, paving the way for smart cities and autonomous vehicles. With the integration of Internet of Things (IoT) devices,intelligent traffic management systems, and advanced driver-assistance systems, tek071 can enhance transportation safety, efficiency, and sustainability. Additionally, the optimization of routes and traffic flow through real-time data analysis can reduce congestion and fuel consumption.2.4 Communication and Connectivity:Tek071 plays a vital role in improving communication and connectivity. With the advent of 5G technology and advanced networking solutions, tek071 enables faster and more reliable connections, promoting seamless communication across devices, platforms, and locations. This opens up opportunities for enhanced collaboration, remote work setups, and efficient data transfer, contributing to increased productivity and innovation.3. Benefits and Challenges:3.1 Benefits:The utilization of tek071 offers numerous advantages, including increased efficiency, cost savings, improved quality, and enhanced user experience. By automating repetitive tasks, improving data analysis capabilities, and supporting decision-making processes, tek071 enables organizations to optimize their operations.3.2 Challenges:However, the implementation of tek071 is not without its challenges. Privacy and security concerns arise as more devices are interconnected and generate vast amounts of data. Ensuring data protection, preventing cyber-attacks, and establishing regulatory frameworks are crucial aspects that need to be addressed. Additionally, the potential displacement of jobs due to automation highlights the need for retraining and upskilling the workforce.4. Future Prospects:The future prospects of tek071 are promising, with ongoing research and development fueling further advancements. Continued innovation, collaboration between different sectors, and investment in infrastructure will shape the future of tek071. Skills in data analysis, AI, cybersecurity, and robotics will be in high demand, creating new job opportunities. As tek071 progresses, seamless integration between human intelligence and technological capabilities will form the basis of a transformative society.Conclusion:Tek071 represents an exciting time of technological advancement and innovation, with its far-reaching impact across multiple sectors. This document has provided anoverview of tek071, exploring its applications, benefits, challenges, and future prospects. As we move closer to a tech-driven future, embracing the potential of tek071 will pave the way for a more connected, efficient, and sustainable world.。

气相色谱-串联质谱法测定罗汉果中22种农药残留量

气相色谱-串联质谱法测定罗汉果中22种农药残留量

气相色谱-串联质谱法测定罗汉果中22种农药残留量任永霞1,黄纯婷2,徐日文1,翁福良1,梁 宁1(1.拱北海关技术中心,广东珠海 519000;2.中山百盛生物技术有限公司,广东中山 528400)摘 要:建立气相色谱-串联质谱法测定罗汉果中22种农药残留量的分析方法。

样品用乙腈提取后经PSA/GCB固相萃取柱净化,采用气相色谱-串联质谱法检测,外标法定量。

结果表明,所有农药在0.005~0.500 μg·mL-1线性关系良好,相关系数R2均大于0.999,方法定量限为0.010 mg·kg-1。

样品中3个加标水平的回收率为71.1%~116.7%,相对标准偏差为0.7%~7.5%。

该方法准确并易于操作,符合农药残留检测要求,可对罗汉果中多种农药进行定性和定量检测。

关键词:罗汉果;气相色谱-串联质谱;固相萃取Determination of 22 Pesticide Residues in Siraitia grosvenorii by Gas Chromatography Tandem Mass Spectrometry REN Yongxia1, HUANG Chunting2, XU Riwen1, WENG Fulang1, LIANG Ning1(1.Technical Center of Gongbei Customs District P.R., Zhuhai 519000, China; 2.Zhongshan PASSION BiotechnologyCo., Ltd., Zhongshan 528400, China)Abstract: A method for the determination of 22 pesticide residues in Siraitia grosvenorii was established by gas chromatography tandem mass spectrometry. The sample was extracted with acetonitrile and purified by PSA/GCB solid-phase extraction column. Gas chromatography tandem mass spectrometry was used for detection, and external standard method was used for quantification. The results showed that all pesticides had good linear relationships within the range of 0.005~0.500 μg·mL-1, with correlation coefficients R2 greater than 0.999. The quantitative limit of the method was 0.010 mg·kg-1. The recoveries of the three spiked levels in the sample were 71.1% ~ 116.7%, with a relative standard deviation of 0.7% ~ 7.5%. The method is accurate and easy to operate, and meets the requirements of pesticide residue detection. It can be used for qualitative and quantitative detection of various pesticides in Siraitia grosvenorii.Keywords:Siraitia grosvenorii; gas chromatography-tandem mass spectrometry; solid phase extraction罗汉果(Siraitia grosvenorii)是葫芦科多年生藤本植物的果实,是国家批准的药食两用食品,具有抗癌、抗氧化、抑菌、免疫、润便通肺以及止咳化痰等功效[1-3]。

ATE Corporation AS-05 Antenna Set 30 MHz to 18 GHz

ATE Corporation AS-05 Antenna Set 30 MHz to 18 GHz

Main Features•30 MHz to 18 GHz frequency range •Excellent Antenna Factor•Tripod adapter for easy vertical-horizontal polarization change •Individual calibration•Robust, rustproof aluminium construction •LightweightAS-05 is a compact size broadband Antenna System composed of a BC-01 Biconical Dipole, LP-04 Log Periodic Dipole Array and DR-01 Double Ridged horn Antenna designed for radiated emissions and immunity testing. It can be used in conjunction with any receiver or spectrum analyzer.Its ideal companion is the EMI Receiver Unit 9060 and 9180 that can be easily mounted on the antenna mast (*).(*)The direct connection between antenna and PMM Receiver Unit eliminates additional sources of uncertainties due to coaxial cable attenuation and scattering. For further information please consult our brochure “Fully CISPR-Compliant Digital EMC/EMI receivers 10 Hz to 18 GHz”.Antenna Set 30 MHz to 18 GHzProvided by: (800)404-ATECAdvanced Test Equipment Rentals®Ordering Information:AS-05 antenna set 30 MHz to 18 GHz with individual calibration reports.AS-05/TC antenna set 30 MHz to 18 GHz with typical calibration reports.Includes: BC-01 biconical antenna; LP-04 Log-periodic antenna; DR-01Double-rideged antenna; TR-01 wooden tripod; RF cable, 6 GHz, N(m)-N(m), 5 m; Soft carrying case; Rigid carrying case (for DR-01), Operating manual; Calibration reports*.* Individual calibration reports are provided with AS-05.AS-05/TC does not include individual calibration but typical antenna factor.Optional accessories:Additional TR-01 Wooden tripod extensible 60 - 180 cm with antenna mounting adapter for fast horizontal to vertical polaritazion changing. Additional RF cable, 3 GHz, N(m)-N(m), 5 m.Sales Office:Via Leonardo da Vinci, 21/2320090 Segrate (Milano) - ITALY Phone: +39 02 2699871Fax: +39 02 26998700Headquarter:Via Benessea, 29/B17035 Cisano sul Neva (SV) - ITALY Phone: +39 0182 58641Fax: +39 0182 586400E-Mail:**************************Internet: www.narda-sts.itRelated ProductsReceiversAntennasCalibrations service• 7010/00: EMI receiver 150 kHz to 1 GHz • 7010/01: EMI receiver 9 kHz to 1 GHz • 7010/03: EMI receiver 9 kHz to 3 GHz • 9010: EMI receiver 10 Hz to 30 MHz • 9010F: EMI receiver 10 Hz to 30 MHz• 9010/03P: EMI receiver 10 Hz to 300 MHz • 9010/30P: EMI receiver 10 Hz to 3 GHz • 9010/60P: EMI receiver 10 Hz to 6 GHz • 9030: EMI Receiver 30 MHz to 3 GHz • 9060: EMI Receiver 30 MHz to 6 GHz •FR-4003: Field Receiver 9 kHz to 30 MHz• LP-02: Log Periodic Antenna 200 MHz to 3 GHz • LP-03: Log Periodic Antenna 800 MHz to 6 GHz • TR-01: Antenna Tripod• VDH-01: Van der Hoofden test-head 20 kHz to 10 MHz • Antenna Set AS-02 (BC01+LP02+TR01)• Antenna Set AS-03 (BC01+LP02+LP03+TR01) • Antenna Set AS-04 (BC01+LP04+TR01)• RA01: Rod Antenna 9 kHz to 30 MHz• RA01-HV: Rod Antenna 150 kHz to 30 MHz •RA01-MIL: Rod Antenna 9 kHz to 30 MHz• Ansi 63,5 Antenna Factor • SAE ARP 958-D• Free-Space Antenna FactorSPECIFICATIONSFrequency range GainAntenna factor Max input power Connector Dimensions (L x H x W)Weight Colour Impedance ConstructionBC-0130 to 200 MHz -15 +2 dBi typical 8 to 14 dB/m typical 100 W N-female 65 x 65 x 137 cm1,8 kg RAL 703550 Ω nominal AluminiumA S 05-F E N -60801 - S p e c i fi c a t i o n s s u b j e c t t o c h a n g e s w i t h o u t p r i o r n o t i c eAS-05Antenna set 30 MHz to 18 GHzLP-04200 MHz to 6 GHz 6 dBi typical 12 to 40 dB/m typical100 W N-female 78 x 10 x 75 cm 1,1 kg RAL 703550 Ω nominal AluminiumDR-016 to 18 GHz 9 to 16 dBi typical 36 to 41 dB/m typical 150 W N-female 55 x 44 x 177 mm 0,25 kg RAL 703550 Ω nominal AluminiumBC-01 - Antenna Factor 106141822A F (d B /m )3090150210MHz MHz MHz MHz LP-04 - Antenna Factor 155253545A F (d B /m )1356GHzGHz GHz GHz DR-01 - Antenna Factor3634384042A F (d B /m )6101418GHzGHz GHz GHz。

Agilent SPME Fiber or Arrow Manual Injection Kit U

Agilent SPME Fiber or Arrow Manual Injection Kit U

12345SPME Fiber or Arrow Manual Injection KitSPME manual samplingThe Agilent manual injection kit will allow the end user to extract samples using SPME fibers or Arrows. They can then inject the samples into a GC inlet.Manual SPME SamplingSPME fibers and Arrowsp/n 5191-58772PAL3 alignment ring (gray) for split/splitless (S/SL) inletManual injectionManual injection guidePAL3 alignment ring (Gray) for S/SL inlet (G7371-67001)The manual injection guide sits on thealignment ring for manual sample injection.3Methodology—manual samplingInstalling a PDMS SPME (100 μm) Arrow into the manual syringeLoosen the cap at the base of the syringe and remove it.Depress the black plunger completely.Screw the hub of an SPME fiber/Arrow into the bottom of the plunger at the end of thesyringe bodyRetract the black plunger and slide the cap over the SPME fiber/Arrow and tighten itonto the syringe.4The extraction guide has two positions where the syringe can be installed.The upper position is used for headspace extraction.The lower position is used for immersion extraction.Incorrect and correct position of the lower locking screw.Do not tighten the screw against the black plunger or you will not be able to move the SPME fiber/Arrow intoposition for sampling.Setting the locking screwsLarge inner diameter (id) locking screwSmall inner diameter (id) locking screwSlide the locking screws onto the syringe from the plunger side (the right side as shown above).• Install the large id locking screw onto the silver body of the syringe.• Install the small id locking screw onto the wider portion of the black plunger.•Tighten the locking screws until finger-tight. Do not overtighten, as they will be adjusted in later steps.5• Raise the syringe plunger to the fully extended position and insert the syringe and lower locking screw into the upper position of the extraction guide.•Lock the syringe into place by rotating it until the locking screw is positioned in the notch.• Adjust the syringe so that the SPME fiber/Arrow is protruding ~1 cm beyond the inner base of the extraction guide (A).• Tighten the lower locking screw securely.•The tip of the SPME fiber/Arrow will be recessed at least 1 mm in from the end ofthe extraction guide (B).A BSetting the locking screws for septum penetration depthPlace the extraction guide (with syringe in place) on a headspace sampling vial and loosen the upper locking screw.Adjust the SPME fiber/Arrow to the desired exposure depth by moving the black plunger.Choose a depth that ensures that the SPME fiber/Arrow will be in the gas phase.Once the SPME fiber/Arrow is at the proper depth, hold the plunger in place and slide the upper locking screw until it is flush against the top of the silver syringe body. Then tighten the upper locking screw securely.Setting the exposure depth for headspace extraction6Fine depth adjustment for direct immersion extractionAdjusting the injector penetration depthInsert the syringe into the lower position of the extraction guide.1. Manual SPME injection guide2. PAL3 alignment ring (gray) forS/SL inlet (G7371-67001)• Carefully insert the syringe into the injection guide.• Use caution to avoid damaging the SPME fiber/Arrow when threading it through the hole in the base of the injection guide.•Lock the syringe into place by rotating it until the locking screw is positioned in the notch.Penetrate a vial and fully expose the SPME fiber/Arrow within the vial.Adjust the lower locking screw and upper locking screw to obtain the desired exposure depth (to ensureimmersion in the sample liquid).127Setting injector penetration depthWith the appropriate GC-specific adaptor cup on the end of the injection guide, measure the distance from the tip of the SPME fiber/Arrow to the groove inside the adaptor cup.Adjust the desorption depth by screwing the body of the injection guide up or down (maximum depth = 67 mm).Twist the locking ring down until it locks on the body of the injection guide./chemDE.3985648148This information is subject to change without notice.© Agilent Technologies, Inc. 2020 Printed in the USA, March 6, 2020 5994-1732ENInjection onto the GC inletRemove the adapter cup from the injection guide.The adapter cup is placed onto the GC inlet to guide the manual injection.Push the plunger down until the top locking screw is resting on the body of the syringe.The sample is then injected.。

Alpha-1-Proteinase Inhibitors产品说明

Alpha-1-Proteinase Inhibitors产品说明

Alpha-1-Proteinase Inhibitors:Aralast NP®; Glassia®; Prolastin®-C; Zemaira®(Intravenous)Document Number: IC-0052 Last Review Date: 04/06/2021Date of Origin: 01/01/2012Dates Reviewed: 12/2011, 02/2013, 08/2013, 06/2014, 06/2015, 01/2016, 10/2016, 03/2017, 09/2017, 12/2017, 03/2018, 06/2018, 04/2019, 04/2020, 04/2021I.Length of AuthorizationCoverage will be provided for 12 months and may be renewed.II.Dosing LimitsA.Quantity Limit (max daily dose) [NDC Unit]:∙Aralast NP 1 g/50 mL: 7 vials per week∙Aralast NP 0.5 g/25 mL: 1 vial per week∙Glassia 1 g/50 mL: 7 vials per week∙Prolastin-C 1 g/20 mL: 7 vials per week∙Prolastin-C Liquid 1g/20 mL: 7 vials per week∙Zemaira 1 g/20 mL: 3 vials per week∙Zemaira 4 g/76 mL: 1 vial per week∙Zemaira 5 g/95 mL: 1 vial per weekB.Max Units (per dose and over time) [HCPCS Unit]:∙700 billable units every 7 daysIII.Initial Approval Criteria1-6,8,9,12•Patient is at least 18 years of age; ANDUniversal Criteria•Patient is not a tobacco smoker; AND•Patient is receiving optimal medical therapy (e.g., comprehensive case management, pulmonary rehabilitation, vaccinations, smoking cessation, self-management skills, etc.);AND•Patient does not have immunoglobulin-A (IgA) deficiency with antibodies against IgA;ANDEmphysema due to alpha-1-antitrypsin (AAT) deficiency †, Ф(applies only to Prolastin-C)•Patient has an FEV1 in the range of 30-65% of predicted; AND•Patient has alpha-1-antitrypsin (AAT) deficiency with PiZZ, PiZ (null), or Pi (null, null) phenotypes; AND•Patient has AAT-deficiency and clinical evidence of panacinar/panlobular emphysema;AND•Patient has low serum concentration of AAT ≤ 57 mg/dL or ≤ 11 µM/L as measured by nephelometry† FDA Approved Indication(s); Ф Orphan DrugIV.Renewal Criteria1-6,8,9Authorizations can be renewed based on the following criteria:•Patient continues to meet universal and other indication-specific relevant criteria such as concomitant therapy requirements (not including prerequisite therapy), performance status, etc.identified in section III; AND•Disease response with treatment as defined by elevation of AAT levels above baseline, substantial reduction in rate of deterioration of lung function as measured by percentpredicted FEV1, or improvement in CT scan lung density; AND•Absence of unacceptable toxicity from the drug. Examples of unacceptable toxicity include severe hypersensitivity reactions, etc.V.Dosage/Administration1-5VI.Billing Code/Availability InformationHCPCS Code & NDC:VII.References1.Glassia [package insert]. Lexington, MA; Baxalta US Inc.; June 2017. Accessed March2021.2.Zemaira [package insert]. Kankakee, IL; CSL Behring LLC; April 2019. Accessed March2021.3.Aralast NP [package insert]. Lexington, MA; Baxalta US Inc.; December 2018. AccessedMarch 2021.4.Prolastin-C Liquid [package insert]. Research Triangle Park, NC; Grifols Therapeutics,Inc.; August 2018. Accessed March 2021.5.Prolastin-C [package insert]. Research Triangle Park, NC; Grifols Therapeutics, Inc.; June2018. Accessed March 2021.6.American Thoracic Society/European Respiratory Society Statement: Standards for theDiagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. AmericanThoracic Society; European Respiratory Society. Am J Respir Crit Care Med. 2003 Oct1;168(7):818-900.7.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for thediagnosis, management, and prevention of chronic obstructive pulmonary disease. GlobalInitiative for Chronic Obstructive Lung Disease (GOLD); 2019.8.Sandhaus RA, Turino G, Brantly ML, et al. The diagnosis and management of alpha-1antitrypsin deficiency in the adult. Chronic Obstr Pulm Dis (Miami). 2016; 3(3):668-682.9.Marciniuk DD, Hernandez P, Balter M, et al. Alpha-1 antitrypsin deficiency targetedtesting and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.Can Respir J. 2012;19(2):109-16.10.Stocks JM, Brantly M, Pollock D, et al. Multi-center study: the biochemical efficacy, safetyand tolerability of a new α1-proteinase inhibitor, Zemaira. COPD. 2006;3:17–23.11.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for thediagnosis, management, and prevention of chronic obstructive pulmonary disease. GlobalInitiative for Chronic Obstructive Lung Disease (GOLD); 2020.12.Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement:diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. Eur Respir J2017; 50.Appendix 1 – Covered Diagnosis CodesAppendix 2 – Centers for Medicare and Medicaid Services (CMS)Medicare coverage for outpatient (Part B) drugs is outlined in the Medicare Benefit Policy Manual (Pub. 100-2), Chapter 15, §50 Drugs and Biologicals. In addition, National Coverage Determination (NCD), Local Coverage Determinations (LCDs), and Local Coverage Articles (LCAs) may exist and compliance with these policies is required where applicable. They can be found at: /medicare-coverage-database/search/advanced-search.aspx. Additional indications may be covered at the discretion of the health plan.Medicare Part B Covered Diagnosis Codes (applicable to existing NCD/LCD/LCA): N/A。

安捷伦产品目录

安捷伦产品目录

15
Real-Time PCR
16
Mx3000P QPCR System
17
Brilliant III Ultra-Fast SYBR Green QPCR and QRT-PCR Reagents
18
Brilliant III Ultra-Fast QPCR and QRT-PCR Reagents
Agilent / STRATAGENE
Agilent website: /genomics
Welgene | Agilent Stratagene
威健股份有限公司 | Stratagene 總代理
Table of Content
Table of Contents
/ XL1-Red Competent Cells SoloPack Gold Supercompetent Cells
/ TK Competent Cells Specialty Cells
/ Classic Cells / Fine Chemicals For Competent Cells
適用於 UNG 去汙染或 bisulphite
sequencing
適用於 TA Cloning
最高敏感性
取代傳統 Taq 的好選擇
-
2
威健股份有限公司 | Stratagene 總代理
PCR Enzyme & Instrument
Agilent SureCycler 8800
市場上領先的 cycling 速度和 sample 體積 10 ~ 100 μL 簡易快速可以選擇 96 well 和 384 well 操作盤 優秀的溫控設備讓各個 well 都能保持溫度的穩定 七吋的高解析度觸控螢幕讓操作上更為簡便 可以透過網路遠端操控儀器及監控儀器 Agilent 專業的技術支援可以幫助您應對各種 PCR 的問題

利乐杀菌机

利乐杀菌机

!E
2400kg 3550kg
F
14,5 + 12,7 m3
பைடு நூலகம்
Tetra Therm Aseptic Flex 1,
!"#$%&'(
Tetra Therm Aseptic Flex 1 J
!
!"#$%&'(
!
ElLhF E6 F 3 F -3200 8000 50 50 !"F 13 -3200 8000 50 13 10500 3200 8000 50 13 15500 3200 8000 50 13 1000 26 4500 115 4500 165 4500 160
!"#$%&'()*%+,= !"#$%&'()*+, -. !"#$%& !"#$%&
!"#$%&'()*+,-
!
!"#$%&'()*+,!-./01 !"#$%&'()*+
= = = =
Tetra Spiraflo MTR &
!"#!$%&'( !" Tetra
!'()*+ !"#
!"#$% &'()*+,-./01 2 !"#$%&'()"*+,-.
Tetra Therm Aseptic Flex 1 J
!"#$%&'()*+,&-./0*+12 !"#$%&'ECIPF EAICF !"#$%!&'()* !"# !"#$%& !"#$%&'( !"#$%&' !"#$ % ! !"#$

Yeastmaker Yeast transformation system 2 PT1172-1[1]

Yeastmaker Yeast transformation system 2 PT1172-1[1]

Clo.

A Takara Bio Company
Protocol No. PT1172–1 Version No. PR0Y3570
3
Yeastmaker™ Yeast Transformation System 2 User Manual
Technical Support tel: 800.662.2566 (toll-free) fax: 650.424.1064 e-mail: tech@
Protocol No. PT1172-1

Version No. PR0Y3570
A. Ready-to-Go Media Pouches Available from Clontech......................................................................... 4 B. General Media Preparation Instructions.............................................................................................. 4 IV. Solutions Required for Yeast Transformation ...................................................................... 5 V. Yeast Cell Stock Maintenance .............................................................................................. 5 VI. Yeast Transformation Protocol............................................................................................... 6 A. Protocol: Preparation of Competent Yeast Cells................................................................................... 6 B. Protocol: Transformation of Competent Yeast Cells............................................................................. 7 C. Protocol: Plating and Determination of Transformation Efficiency...................................................... 8 VII. References .............................................................................................................................. 9
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Unit
V V V V V V °C °C mW
PSOP-8 PSOP-8
36 5.5 2
°C /W °C /W kV
ESD Rating (Human Body Model) (Note 3)
Ver. E1.0
3
AT7577
2A Step Down Voltage Regulator with Operational Amplifier
1.5% 1.211Biblioteka 1.2301.249
V
2%
1.205
1.230
1.255
V
Efficiency
η
82
%
Feedback Bias Current Oscillator Frequency
IFB FOSC
10 42 * 0.5 * 93 98 0.5 3.5 5 0.1 3 52
PIN CONFIGURATIONS (TOP VIEW)
Ver.E1.0
1
AT7577
2A Step Down Voltage Regulator with Operational Amplifier
Immense Advance Tech.
PIN DESCRIPTIONS
Pin Name
VIN SHDN GND FB Input supply voltage. Regulator shutdown control input. Driver SHDN pin above 3V to shutdown and below 2V to enable regulator output. Ground. Feedback Input. FB senses the output voltage to regulate that voltage. Drive FB with a resistive voltage divider from the output voltage. Power Switching Output. SW is the switching node that supplies power to the output. Connect the output LC filter from SW to the output load. Over voltage protection. Current Sensing, connect to negative input of internal OCP comparator. Current Sensing, connect to Positive input of internal OCP comparator. Pad for heat-sinking purpose. Connect to ground plane using multiple vias. Not electrically connected internally.
Immense Advance Tech.
BLOCK DIAGRAM
ABSOLUTE MAXIMUM RATINGS (Note1)
Parameter
Maximum supply Voltage FB Pin Voltage SHDN Control Pin Voltage Switch Output Pin Voltage OCP Comparator Input Voltage OVP Comparator Input Voltage Maximum Junction Temperature Lead Temperature (Soldering, 5sec) Power Dissipation PD @ TA=25°C Thermal Resistance (Note 2) Thermal Resistance PSOP-8(Exposed Pad)
GND Cin 470uF/50V 2 FB SHDN OVP 4 7 D1 SK24 Cout 470uF/10V
3
1nF
R6 100K
330pF
R2 100K
GND
Figure 1: AT7577-ASF8
Ver. E1.0
2
AT7577
2A Step Down Voltage Regulator with Operational Amplifier
Symbol
VIN TJ TA
Operation Conditions
8V to 40V -40°C to +125°C -40°C to +85°C
Unit
V °C °C
Note 1: Stresses listed as the above “Absolute Maximum Ratings” may cause permanent damage to the device. These are for stress ratings. Functional operation of the device at these or any other conditions beyond those indicated in the operational sections of the specifications is not implied. Exposure to absolute maximum rating conditions for extended periods may remain possibility to affect device reliability. Note 2: 2 square inch of FR-4, double sided, 1 oz. minimum copper weight. Note 3: Devices are ESD sensitive. Handling precaution recommended. Note 4: The device is not guaranteed to function outside its operating conditions.
AT7577
2A Step Down Voltage Regulator with Operational Amplifier
Immense Advance Tech.
FEATURES

DESCRIPTION
The AT7577 allows introducing an additional adjustment for the Over Current Protection (OCP) and Over Voltage Protection (OVP). In this case the OCP and OVP value can be changed with help external resistors. The AT7577 provides all the active functions for a step-down (buck) switching regulator and is capable of driving 2A load with excellent line and load regulation. It includes an internal frequency compensation components and a fixed-frequency oscillator. Among other features are a guaranteed ±2% tolerance on an output voltage within the specified input voltages and output load conditions. External shutdown is included. The output switch includes cycle-by-cycle current limiting and thermal shutdown elements for a full protection under fault conditions. The high gain, internally frequency-compensated operational amplifiers were designed specifically to operate from a single power supply over a wide range of voltages.
Output Voltage Range, 1.23V to 37V ±2% Guaranteed 2A Output Current Wide Input Voltage Range, 40V 52KHz Fixed Frequency Oscillator TTL Shutdown capability, Low Power Standby Mode High Efficiency Thermal Shutdown and Current Limit Protection Low Input Offset Voltage and offset Current of Comparator for OCP Internal Frequency Compensation of Err-Amp Over Voltage Protection (OVP)


APPLICATION

Car Charger with OVP and OCP
ORDER INFORMATION
AT 7577- X.X SF8 R
IAT Circuit Type Output Voltage: A: ADJ; 5.0: 5.0V SF8: PSOP-8 Shipping: R: Tape & Reel
Pin Description
相关文档
最新文档